Salk scientists develop new technique to heal large ulcers by reprogramming wound cells into skin cells
Plastic surgery to treat large cutaneous ulcers, including those seen in people with severe burns, bedsores or chronic diseases such as diabetes, may someday be a thing of the past. Scientists at the Salk Institute have developed a technique to directly convert the cells in an open wound into new skin cells. The approach relies on reprogramming the cells to a stem-cell-like state and could be useful for healing skin damage, countering the effects of aging and helping us to better understand skin cancer.
“Our observations constitute an initial proof of principle for in vivo regeneration of an entire three-dimensional tissue like the skin, not just individual cell types as previously shown,” says Salk Professor Juan Carlos Izpisua Belmonte, holder of the Roger Guillemin Chair and senior author of the new paper, published in the journal Nature on September 5, 2018. “This knowledge might not only be useful for enhancing skin repair but could also serve to guide in vivo regenerative strategies in other human pathological situations, as well as during aging, in which tissue repair is impaired.”
Cutaneous ulcers—wounds that can extend through multiple layers of the skin—are typically treated surgically, by transplanting existing skin to cover the wound. However, when the ulcer is especially large, it can be difficult for surgeons to graft enough skin. In these cases, researchers are able to isolate skin stem cells from a patient, grow them in the lab and transplant them back into the patient. However, such a procedure requires an extensive amount of time, which may put the patient’s life at risk and is sometimes not effective.
Izpisua Belmonte and Salk Research Associate Masakazu Kurita, who has a background in plastic surgery, knew that a critical step in wound recovery was the migration—or transplantation—of basal keratinocytes into wounds. These stem-cell-like cells act as precursors to the different types of skin cells. But large, severe wounds that have lost multiple layers of skin no longer have any basal keratinocytes. And even as these wounds heal, the cells multiplying in the area are mainly involved in wound closure and inflammation, rather than rebuilding healthy skin.
Izpisua Belmonte and Kurita wanted to directly convert these other cells into basal keratinocytes—without ever taking them out of the body. “We set out to make skin where there was no skin to start with,” says Kurita.
The researchers first compared the levels of different proteins of the two cell types (inflammation and keratinocytes) to get a sense of what they’d need to change to reprogram the cells’ identities. They pinpointed 55 “reprogramming factors” (proteins and RNA molecules) that were potentially involved in defining the distinct identity of the basal keratinocytes. Then, through trial and error and further experiments on each potential reprogramming factor, they narrowed the list down to four factors that could mediate the conversion to basal keratinocytes.
When the team topically treated skin ulcers on mice with the four factors, the ulcers grew healthy skin (known as epithelia) within 18 days. Over time, the epithelia expanded and connected to the surrounding skin, even in large ulcers. At three and six months later, the generated cells behaved like healthy skin cells in a number of molecular, genetic and cellular tests.
The researchers are planning more studies to optimize the technique and begin testing it in additional ulcer models.
“Before going to the clinic, we have to do more studies on the long-term safety of our approach and enhance the efficiency as much as possible,” says Kurita.
The Latest on: Reprogramming cells
via Google News
The Latest on: Reprogramming cells
- Penn study opens the door to let CAR T cells reach the tumor microenvironmenton November 30, 2020 at 3:03 pm
The labyrinth of jumbled blood vessels in the tumor microenvironment remains one of the toughest blockades for cellular therapies to penetrate and treat solid tumors.
- Penn researchers unlock the door to tumor microenvironment for CAR T cellson November 30, 2020 at 8:04 am
T cell therapy with a PAK4 inhibitor drug allowed the engineered cells to punch their way through and attack solid tumors, leading to significantly enhanced survival in mice.
- Researchers unlock the door to tumor microenvironment for CAR T cellson November 30, 2020 at 8:01 am
The labyrinth of jumbled blood vessels in the tumor microenvironment remains one of the toughest blockades for cellular therapies to penetrate and treat solid tumors. Now, in a new study published ...
- Boosting stem cell activity can enhance immunotherapy benefitson November 23, 2020 at 12:01 pm
Immune-system T cells have been reprogrammed into regenerative stem cell-like memory (TSCM) cells that are long-lived, highly active 'super immune cells' with strong antitumor activity, according to ...
- Reprogramming T cells into highly active 'super immune cells' can improve immunotherapy benefitson November 23, 2020 at 10:43 am
Immune-system T cells have been reprogrammed into regenerative stem cell-like memory (TSCM) cells that are long-lived, highly active "super immune cells" with strong antitumor activity, according to ...
- Scientists Reengineer Immune Cells in Step towards Possible Cure for HIVon November 21, 2020 at 12:50 am
Scientists generated new hope for a cure after they created a durable and long-lasting defense against HIV infection, using genetically engineered immune cells from a patient's body.
- Major HIV vaccine breakthrough as scientists reengineer immune cells in step towards possible cureon November 20, 2020 at 7:28 am
A new vaccine approach using genetically engineered immune cells from a patient's body has created a durable and long-lasting defense against HIV infection, generating new hope not just for a vaccine, ...
- Engineered immune cells, new hope for HIV vaccine: Researchon November 20, 2020 at 2:08 am
Scientists at Scripps Research have moved closer to attaining a triumph over HIV research with a new vaccine approach that would anticipate engineered immune ce ...
- Duke researchers use stem cell models to test therapies for lung infections including coronaviruseson November 20, 2020 at 2:00 am
Duke researches now use artificial human "mini-lungs" for testing new therapies to beat COVID-19. They may also be able to repair lung damage from the virus.
- Engineered immune cells elicit broad response to HIV in mice, offering hope for vaccineon November 19, 2020 at 1:13 pm
Unlike so many other deadly viruses, HIV still lacks a vaccine. The virus—which continues to infect millions around the world—has proven especially tricky to prevent with conventional antibodies, in ...
via Bing News